In article <2tr2oe$6an at netnews.upenn.edu>,
Kurt A. Kistler <kistler at a.chem.upenn.edu> wrote:
>>I believe Tacrine is on the U.S. market now, even though it does not
>do such a great job. Are AChE inhibitors a waste of time?
I recently talked with someone who works in this field, and he told me
that AChE inhibitors actually make the problem worse. Patients
see an increase in dimentia and a whole host of other problems
lmk2 at garnet.berkeley.edu